Lobbying, Healthcare, and Foreign Policy Dynamics

This chapter examines the intricate relationship between lobbying, particularly by pharmaceutical companies, and its impact on federal policy, alongside the missed opportunities of political leaders to confront corporate interests. It transitions into a critical analysis of Kamala Harris's stance on U.S. foreign policy concerning Israel and Palestine, emphasizing the need for definitive policy changes. Through these discussions, the chapter highlights the intersection of health care, community well-being, and the influence of political rhetoric on public perception.